German health tech firm developing cloud-based automated ECG analysis and atrial fibrillation detection software for stroke risk prevention in clinics.
apoplex medical technologies GmbH builds automated applications for atrial fibrillation detection and stroke risk prevention. Founded in 2004, the German health technology company develops cloud-based clinical software for automated ECG analysis, aimed at identifying stroke risk at an early stage and supporting preventive decision-making in clinical settings. Its technical work spans signal analysis, medical diagnostics and cloud delivery of clinical tools.
The company's flagship system, SRA (Stroke Risk Analysis), performs automated ECG analysis to help medical professionals detect stroke risk and take targeted preventive measures. It is cloud-based and accessible at any time. Reported figures include 2x higher detection rates and 3x faster detection of paroxysmal atrial fibrillation (pAF), with a 96% negative predictive value.
More than 20 studies worldwide are cited as evidence of the system's performance. SRA is in use at more than 200 clinics globally and is used by 40% of Stroke Units in Germany. The company works across cardiology, stroke care and clinical medicine, with the stated aim of easing preventive work in everyday clinical practice.
apoplex medical technologies operates in Germany with an international clinic base. Over 20 years since its founding in 2004, it has focused on stroke risk detection and management for clinics and stroke units.
